leaves to isolate the active metabolites and test their effect on the MCF-7 breast cancer cell line as well as evaluation of their epithelial growth factor receptor (EGFRwt) kinase and aromatase (CYP19A) enzyme inhibition activity. The gene discussed is CYP19A1; the disease is breast carcinoma.